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Background:GPSM3, a guanine nucleotide dissociation inhibitor acting onGi subunit familymembers, is both cytoplasm-
and nucleus-localized.
Results: GPSM3 interacts directly with 14-3-3 through a phosphorylation-dependent mechanism.
Conclusion: Interaction with 14-3-3 stabilizes a cytoplasmic pool of GPSM3.
Significance: Our findings represent the first demonstration of post-translational modulation of GPSM3, a hematopoietic-
restricted G-protein subunit regulator.
G-protein signaling modulator-3 (GPSM3), also known as
G18 or AGS4, is a member of the Gi/o-Loco (GoLoco) motif
containing proteins.GPSM3acts through its twoGoLocomotifs
to exert GDP dissociation inhibitor activity over Gi subunits;
recently revealed is the existence of an additional regulatory site
within GPSM3 directed towardmonomeric G subunits during
their biosynthesis. Here, using in silico and proteomic
approaches, we have found that GPSM3 also interacts directly
with numerous members of the 14-3-3 protein family. This
interaction is dependent onGPSM3phosphorylation, creating a
mode II consensus 14-3-3 binding site. 14-3-3 binding to the
N-terminal disordered region of GPSM3 confers stabilization
fromprotein degradation. The complex ofGPSM3 and 14-3-3 is
exclusively cytoplasmic, and both moieties mutually control
their exclusion from the nucleus. Phosphorylation of GPSM3by
a proline-directed serine/threonine kinase and the resultant
associationof 14-3-3 is the first descriptionof post-translational
regulation of GPSM3 subcellular localization, a process that
likely regulates important spatio-temporal aspects of G-pro-
tein-coupled receptor signaling modulation by GPSM3.
G-protein-coupled receptors regulate numerous essential
biological functions. They are key signal transducers of thou-
sands of extracellular stimuli, regulating a plethora of cellular
outcomes (1–4). Typically, during the cycle of activation, the
ligand-occupied G-protein-coupled receptor promotes the
exchange of guanosine diphosphate (GDP) for guanosine
triphosphate (GTP) by the heterotrimeric G-protein  subunit.
This active, GTP-bound G subunit will thus dissociate from
the G dimer and modulate intracellular effectors such as
adenylyl cyclases and phospholipases (5, 6). Signal termination
is regulated by the action of “regulator of G-protein signaling”
(RGS) proteins that enhance the intrinsicGTPase activity of the
G subunit (7, 8). The inactive, GDP-bound G subunit is gen-
erally thought to reassociate with the G dimer to form the
inactive heterotrimer. However, a more recently discovered
family of G-protein modulators, containing the conserved
GoLoco2 motif, also interacts with inactive, GDP-bound G
subunits of the Gi subfamily known to inhibit adenylyl cyclases
(8–10). The GoLoco motif interaction inhibits spontaneous
GDP release by the bound Gi subunit (11, 12) and also
occludes its G binding site (13), thereby inhibiting reassocia-
tion with G (14).
Inmammalian cells, several differentGoLocomotif-contain-
ing proteins are expressed, including RGS12 and -14,
Rap1GAP, Pcp-2, AGS3, and LGN (8, 15–17). The latter pro-
tein is particularly important for spindle orientation during
asymmetric cell division (reviewed in Ref. 10). Another protein
containing this motif, called GPSM3, has a restricted expres-
sion profile to hematopoietic cell lineages (18–20). Recently,
GPSM3was found not only to modulate heterotrimeric G-pro-
tein subunit signaling through its two activeGoLocomotifs, but
also to affect monomeric G subunit biosynthesis and stability
(20). In the same yeast two-hybrid screen that identified G
subunits asGPSM3-interacting proteins (20), we also identified
multiple isoforms of 14-3-3 as potential GPSM3 binding part-
ners. 14-3-3 proteins are conserved regulatory molecules
expressed in all eukaryotic cells (21, 22). Seven 14-3-3 isoforms
* This work was supported, in whole or in part, by National Institutes of Health
Grants R01 GM082892 (to D. P. S.) and R01 AI088255 (to J. A. D.). This work
was also supported by a Burroughs Wellcome Fund Career Award for Med-
ical Scientists (to J. A. D.), NIAMS Postdoctoral Fellowship F32 AR057644 (to
E. A. O.) from the National Institutes of Health, and postdoctoral fellow-
ships from the Heart and Stroke Foundation of Canada and Fond de la
recherche en santé Quebec (to P. M. G. and G. L.).
□S This article contains supplemental Figs. S1–S3.
1 To whom correspondence should be addressed: 3051 Health Sciences Cen-
ter, One Medical Center Dr., Robert C. Byrd Health Sciences Center, Mor-
gantown, WV 26506-9229. Tel.: 304-293-4991; E-mail: dpsiderovski@
hsc.wvu.edu.
2 The abbreviations used are: GoLoco, Gi/o-Loco; GPSM3, G-protein signal-
ing modulator-3; GSK3, glycogen synthase kinase 3; BRET, biolumines-
cence resonance energy transfer; RLuc, Renilla luciferase; BiFC, bimolecular
fluorescence complementation; Ni-NTA, nickel-nitrilotriacetic acid; pS,
phosphoserine; SPR, surface plasmon resonance.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 287, NO. 37, pp. 31270 –31279, September 7, 2012
© 2012 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.
31270 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 287 • NUMBER 37 • SEPTEMBER 7, 2012
have been identified in mammals (/, , , /, , , and 	).
14-3-3 proteins are ubiquitously expressed, although different
isoforms show some degree of tissue specificity (21). Multiple
proteins have been reported to interact with 14-3-3 isoforms;
these 14-3-3 interactors are known to regulate a wide range of
cellular activities such as cell signaling, cytoskeleton organiza-
tion, cellular trafficking, cell proliferation, apoptosis, metabolic
pathways, and others (21, 22). Here, we have validated the
GPSM3/14-3-3 interaction,mapped the region onGPSM3 crit-
ical for this interaction, and examined the relationship between
both proteins on their subcellular localization.
EXPERIMENTAL PROCEDURES
Commercial Antibodies, Constructs, and Other Reagents—
Horseradish peroxidase (HRP)-conjugated anti-hemagglutinin
(HA) monoclonal antibody (clone 3F10) was obtained from
Roche Applied Science. Anti--actin, anti-FLAGM2 antibody,
and agarose-conjugated anti-FLAG M2 antibody were pur-
chased from Sigma. HRP-conjugated goat anti-mouse and goat
anti-rabbit antibodies were from GE Healthcare. Polyclonal
pan anti-14-3-3 antibody was from Santa Cruz Biotechnology
(Santa Cruz, CA). Monoclonal anti-GPSM3 antibody was pro-
duced in-house and has been previously described (20). All
cDNAs used in this study were cloned in the pcDNA3.1 back-
bone vector (Invitrogen), with FLAG or HA epitope tag
sequences included in the forward PCR primer to produce
N-terminal tagged open reading frames as described previously
(20) or in the reverse PCR primer to produce C-terminal tagged
GSK3. All mutagenesis was performed using the QuikChange
site-directed mutagenesis kit following the manufacturer’s rec-
ommendations (Agilent Technologies, Santa Clara, CA).
Cell Culture and Transfection—Human embryonic kidney
293 (HEK293) and THP-1 cell lines were each obtained from
the American Type Culture Collection (ATCC) and main-
tained in DME medium or RPMI 1640 medium (Invitrogen),
respectively, supplemented with 10% fetal bovine serum (Cell-
gro, Manassas, VA) at 37 °C in a humidified atmosphere con-
taining 5% CO2. Transient transfections of cell monolayers
grown to 75–90% confluence were performed using Lipo-
fectamine 2000 (Invitrogen) according to the manufacturer’s
instructions.
Immunoprecipitation and Immunoblotting—Cells were
lysed with ice-cold lysis buffer (20 mM HEPES, pH 7.5, 1 mM
EDTA, 150mMNaCl, 1%Nonidet P-40, andComplete protease
inhibitor mixture tablets (Roche Applied Science)) at 4 °C on a
rocker platform for 30 min. Lysates were clarified by centrifu-
gation at 16,000  g for 15 min at 4 °C and quantified by the
bicinchoninic acid (BCA) protein content assay (Pierce). For
immunoprecipitation, lysates were incubated with specific
antibody for 2 h at 4 °C followed by overnight incubation with
protein-A/G agarose (Santa Cruz Biotechnology) or directly
incubated with agarose-conjugated anti-FLAG M2 antibody
overnight. Pelleted antibody/bead complexes were then
washed three times with lysis buffer, and proteins were eluted
in Laemmli buffer. Eluted proteins or lysate samples were
resolved on 4–12% precast SDS-polyacrylamide gels (Novex/
Invitrogen), transferred to nitrocellulose, immunoblotted using
primary and HRP-conjugated secondary antibodies, and visu-
alized by chemiluminescence (ECL, GE Healthcare).
Mass Spectrometry Analysis—Immunoprecipitation of FLAG-
tagged GPSM3 and subsequent mass spectrometric identifica-
tion of co-immunoprecipitating proteins were performed as
described previously (20). For post-translational modification
analysis, FLAG-tagged GPSM3 immunocomplex beads were
submitted to the Systems Proteomics Center of University of
North Carolina School (UNC)-Chapel Hill (directed by Dr.
Oscar Alzate) and analyzed for post-translational modification
using two-dimensional-differential in gel electrophoresis (23).
Phosphorylation detected within GPSM3 was further analyzed
using tandem mass spectrometry.
Bioluminescence Resonance Energy Transfer (BRET)—HEK293
cells were seeded in 12-well plates (3.5  105 cells/well) and
transfected with a fixed amount of 14-3-3-RLuc vector DNA
(50 ng), increasing amounts of GFP10-GPSM3 vector DNA
(0–1500 ng), and corresponding (decreasing) amounts of
pcDNA3 empty vector (1500–0 ng) to obtain a saturation
curve. The other BRET assays were performed by transfecting
cells with 50 ng of the Renilla luciferase (RLuc) fusion protein-
expressing vector with 750 ng of GFP10 fusion protein express-
ing vector with 750 ng of additional “challenge” constructs or
pcDNA3 vector. 24 h after transfection, cells werewashed once,
harvested, resuspended in BRET buffer (phosphate-buffered
saline with 1 mM CaCl2, 0.5 mM MgCl2, 0.1% glucose), and dis-
tributed in white 96-well microplates. BRET was initiated by
adding coelenterazine-400a at a final concentration of 5 
M.
Measurements of emitted light were collected on a Mithras
LB-940 plate reader (Berthold Technologies) using a BRET2
filter set.
Bimolecular Fluorescence Complementation (BiFC)—Fusion
constructs were made similar to those previously described for
G/GPSM3 tracking (20): namely, a fusion of the N-terminal
fragment (amino acids 1–158) of yellow fluorescent protein
(YN) to theN terminus of full-lengthGPSM3 (YN-GPSM3) and
the C-terminal fragment (amino acids 159–238) of YFP (YC) to
the C terminus of 14-3-3 (14-3-3-YC). HEK293 cells were
transfected with an equal amount of plasmids encoding the
fusion proteins YN-GPSM3 and 14-3-3-YC, and cells were
incubated at 37 °C for 24 h. Total DNA quantity was normal-
ized using empty pcDNA3.1 vector DNA. To measure fluores-
cence from formed complexes, transfected cells were washed,
harvested, and resuspended in PBS. BiFC signal was acquired
using a Mithras LB-940 plate reader using an excitation/emis-
sion filter set of 485 and 510 nm. The level of expression of each
fusion protein was quantified byWestern blotting using a poly-
clonal antibody directed against the GFP.
ImmunofluorescenceMicroscopy—HEK293 cellswere seeded
in a 12-well plate and transfected with 0.4 
g of each DNA:
YN-GPSM3 and 14-3-3-YC. The following day, cells were
transferred to a poly-D-lysine-coated coverslip in a 6-well plate
and grown overnight. Cells were then fixed with 4% parafor-
maldehyde plus PBS for 10 min at room temperature. Cells
were then washed with PBS and permeabilized with 0.1% Tri-
ton X-100 plus PBS for 30 min at room temperature. Nonspe-
cific bindingwas blockedwith 0.1%TritonX-100 plus PBS con-
taining 5% nonfat dry milk for 30 min at room temperature.
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Cells were then incubated with an anti-HA FITC conjugate
antibody (Roche Applied Science) for 1 h at room temperature
in PBS supplemented with 5% nonfat dry milk. Cells were then
washed three times with permeabilization buffer. Finally, cov-
erslips were mounted using VECTASHIELD mounting
medium containing DAPI (Vector Laboratories, Burlingame,
CA) and examined by inverted fluorescence microscopy
(Olympus IX70) using a 40 objective.
Protein Purification and Surface Plasmon Resonance—Full-
length, N-terminal His-tagged, human 14-3-3 protein was
produced recombinantly in bacteria from a pET vector-based
prokaryotic expression construct using previously described
cloning, expression, and purification techniques (24). His6-
GPSM3 protein from bacteria (pET-based vector) or Sf9 insect
cells (pIEX-Bac3 based baculovirus) was purified by Ni-NTA
affinity chromatography under denaturing conditions and
refolded on-column with cold refolding buffer (20 mM HEPES,
pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 1 mM DTT). Protein
was then eluted with refolding buffer containing 250 mM imid-
azole and buffer-exchanged into 20mMHEPES, pH7.5, 150mM
NaCl, 1 mM DTT, 30 mM CHAPS. Immobilization of His6-14-
3-3 and optical detection of protein binding via surface plas-
mon resonance (Biacore 3000; GE Healthcare) was conducted
as described previously (24).
RESULTS AND DISCUSSION
Interaction between GPSM3 and 14-3-3 Family Members
Stabilizes GPSM3—The N-terminal 50 amino acids of GPSM3
are of low complexity and predicted (44) to be disordered (e.g.
supplemental Fig. S1). Truncation of the first 30 amino acids
has little or no effect on ectopic GPSM3 expression (Fig. 1A).
However, N-terminal deletion beyond 30 amino acids was
observed to dramatically reduce levels of expressed GPSM3.
Analysis of the primary sequence revealed the presence of a
potential binding site for 14-3-3 between amino acids 31 and 40
(supplemental Fig. S2A). 14-3-3 binding sites are often localized
within disordered regions of a protein; it is thought that inter-
action with disordered regions facilitates ligand capture and
transition from a disordered to ordered state that stabilizes
complex formation (25, 26).
As described previously (20), a yeast two-hybrid screen of a
human leukocyte cDNA librarywas performed to identify novel
interacting partners of GPSM3; as shown in Fig. 1B, numerous
clones and isoforms of 14-3-3were identified in this screen. Fig.
1C demonstrates the specific interaction between full-length
GPSM3 used as bait and one of the retrieved 14-3-3 clones,
identified as the full-length 14-3-3 isoform. An additional
approach taken to identify GPSM3 binding partners, also
described previously (20), employed tandem mass spectrome-
try identification of proteins present in an immunoprecipitated
complex of ectopically expressed, FLAG-tagged GPSM3, con-
firming the presence of multiple isoforms of 14-3-3 (Fig. 1D).
14-3-3 proteins were initially discovered as phosphoserine-
binding proteins, although phosphorylation-independent in-
teractions have also been reported (22, 26). Consensus recog-
nition motifs for 14-3-3 binding targets, although not absolute,
are R(S/)()pSXP (mode I) and RX(/S)()(pS)XP (mode II)
where pS is phosphoserine,  is a basic amino acid,  is an
aromatic residue, and X is any type of residue (25, 27). Analysis
of the primary sequence of GPSM3 revealed three potential
14-3-3 interaction sites: site 1, R31PWR34SAP; site 2,
RS54AS56LLS; and site 3, RS153RPPT157H (supplemental Fig.
S2). The last two sites do not match perfectly with the consen-
FIGURE 1. Interaction between GPSM3 and multiple 14-3-3 family members. A, truncation of the GPSM3 N terminus reveals a region between amino acids
31 and 40 essential for stable expression. HEK293 cells were transfected with N-terminal FLAG-tagged GPSM3 expression vectors encoding the indicated amino
acid spans. Lysates were resolved by 4 –12% SDS-PAGE and immunoblotted (IB) with anti-FLAG and anti--actin antibodies. B, a yeast two-hybrid screen was
performed using full-length GPSM3 as bait on a human leukocyte cDNA library (20). Four different 14-3-3 isoforms, in single or multiple copies, were identified
as shown. C, Saccharomyces cerevisiae yeast were co-transformed with the indicated bait plasmids (either expressing the Gal4p DNA binding domain alone
(pAS2-1) or as a fusion with full-length GPSM3 (pAS2-1/GPSM3)) and prey plasmids (either expressing the Gal4p activation domain alone (pGAD424) or as a
fusion with the entire human 14-3-3 / open reading frame (pACT2/14-3-3)). Transformed yeast were plated onto synthetic defined agar (Yc) lacking leucine
(Leu, to select for the prey plasmid) and tryptophan (Trp, to select for the bait plasmid); growth on Yc Leu Trp medium demonstrates incorporation of
both bait and prey plasmids (left panel). Growth on Yc Leu Trp medium also deficient in adenine (Ade) and histidine (His) indicates a positive protein-
protein interaction (right panel). D, tandem mass spectrometry analysis confirmed the promiscuous interaction of GPSM3 with multiple isoforms of 14-3-3.
Immunoprecipitated FLAG-GPSM3 and co-immunoprecipitated proteins were resolved by 4 –12% SDS-PAGE, proteins visualized by SYPRO Ruby staining, and
an apparent band at 30 – 40 kDa was excised for LC/MS/MS peptide sequence identification. All 14-3-3 hits and their spectral counts are shown.
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sus motifs, but numerous 14-3-3 binding partners contain
sequences that differ significantly from these optimal motifs
(27). On the other hand, site 1 possesses all requirements for an
optimal mode II 14-3-3 interaction (supplemental Fig. S1).
Moreover, tandemmass spectrometry analyses of post-transla-
tional modifications on immunoprecipitated GPSM3 indicated
that serines 35, 39, and 153 and threonine 157 are phosphory-
lated under basal conditions (e.g. supplemental Fig. S3). These
two phosphorylated-residue clusters, Ser-35/Ser-39 and Ser-
153/Thr-157, represent two of the three potential 14-3-3 inter-
action sites (namely, sites 1 and 3).
Mapping the Interaction between GPSM3 and 14-3-3 and Its
Consequence on GPSM3 Stability—To confirm whether
GPSM3 interacts with 14-3-3 proteins and identify the motif
involved, we introduced point mutations into full-length,
FLAG-tagged GPSM3 and its interaction with HA-tagged
14-3-3 was assessed by co-immunoprecipitation. We first
observed that point mutation of arginines 31 and 34
(R31,34A),3 serine 35 (S35A), or serine 39 (S39A) within
GPSM3 each reduced the level of ectopically expressedGPSM3
protein observed (Fig. 2A); doubling the quantity of cDNA of
each mutant resulted in a similar level of expression to that of
wild-type GPSM3. We then used these altered transient trans-
fection conditions to test their relative capability to co-immu-
noprecipitate with HA-tagged 14-3-3. The R31,34A and S35A
point mutants of GPSM3 failed to interact with 14-3-3, and a
considerable reduction of the interactionwas observedwith the
S39Amutant (Fig. 2,B andC); these observations confirm site 1
of GPSM3 as important to the binding of 14-3-3. Mutations to
GPSM3 residues R31,34 and Ser-35 were also seen to affect its
interactions with the/ and isoforms of 14-3-3, whereas the
S39A mutation reduced interaction with 14-3-3 / and  iso-
forms but had little effectwith the 14-3-3 isoform (Fig. 2,C,D,
and E). As already described for other 14-3-3 substrates (27),
mutation of GPSM3 residue serine 35 or 39 to aspartic acid was
found to be ineffective in providing a phosphomimetic residue
that enhances 14-3-3 binding (Fig. 2, C, D, and E). No effect on
14-3-3 binding was observed with S56A, S153A, or T157A
mutations to GPSM3 (Fig. 2B), excluding the other two sites
identified in silico.
Arginine 56 within 14-3-3 is essential for phosphoserine
recognition (28–30). We observed that the interaction with
wild-type GPSM3 was considerably reduced by introducing a
R56A mutation into HA-tagged 14-3-3 (Fig. 2F); when com-
bined with the partial loss-of-function S39A GPSM3 mutant,
the R56A 14-3-3 mutation completely abolished the interac-
tion (Fig. 2F).
Two additional point mutants of 14-3-3 isoforms have been
well characterized; mutation of serine 58, known to be phos-
phorylated by PKA or PKB/AKT1, to alanine (S58A) induces
constitutive dimerization of 14-3-3, whereas mutation of this
serine to aspartic acid (S58E) abrogates dimerization (31–33).
However, as shown in Fig. 2G, neither of these mutations to
serine 58 affected interaction with GPSM3, suggesting that the
GPSM3 interactionwith 14-3-3 is independent of the dimeriza-
tion status of 14-3-3. Homo- and heterodimerization of 14-3-3
proteins is thought to be important for their cellular functions
(33). The 14-3-3 dimer adopts a cup-like shape that can interact
simultaneously with two binding sites within the same protein,
thereby inducing conformational change and regulating pro-
tein activity or regulating other interactions via competition or
occlusion. The presence of only one 14-3-3 binding site in
GPSM3 and the binding of either dimeric ormonomeric 14-3-3
to GPSM3 suggest that the 14-3-3 interaction could represent
an important scaffolding function and/or stabilize formation of
a multiprotein complex (21, 25).
The decreased stability of the 14-3-3 binding loss-of-func-
tion GPSM3 mutant R31,34A was further explored. FLAG-
tagged GPSM3 was expressed in HEK293 cells in the presence
or absence of 200
g/ml cycloheximide to blockde novoprotein
synthesis, andGPSM3protein levels were subsequently tracked
over time by Western blotting. Only prolonged incubation
(12 h) with cycloheximide was seen to dramatically reduce
the protein level of wild-type GPSM3 (Fig. 3). In contrast, the
R31,34Amutant of GPSM3 was found to have reduced expres-
sion following 6 h of cycloheximide treatment and was almost
undetectable at 12 h after treatment (Fig. 3), indicating that the
loss-of-functionmutant has reduced stability as comparedwith
wild-type GPSM3.
Endogenous GPSM3 Associates with Endogenous 14-3-3 in a
Monocytic Cell Line—GPSM3 is proposed to be a hematopoi-
etic restricted protein, and we have previously shown that the
humanmonocytic cell line THP-1 expresses detectable levels of
endogenous GPSM3 (20). The interaction between endoge-
nousGPSM3and 14-3-3 proteinswas confirmed inTHP-1 cells
using co-immunoprecipitation with an in-house anti-GPSM3
monoclonal antibody as well as a polyclonal pan-14-3-3 anti-
body (Fig. 2H).
Characterization of the Interactions between GPSM3 and Its
Binding Partners Using BRET—We also examined the interac-
tions between GPSM3, 14-3-3, and G-protein subunits in a cel-
lular context using BRET between RLuc- and green fluorescent
protein (GFP10)-tagged fusions. Saturation BRET has been
established as a robust measure of the specificity of an interac-
tion (34). HEK293 cells transfected with a constant amount of
14-3-3-expressing donor construct (14-3-3-RLuc) and increas-
ing amounts of the GPSM3 acceptor fusion expression vector
(GFP10-GPSM3) were observed to produce a net BRET signal
resulting in a saturable curve (Fig. 4A); mutation of the two
arginines within the 14-3-3 binding site of GPSM3 (mutant
R31,34A; Fig. 2C) eliminated BRET under the same experimen-
tal conditions (Fig. 4A). In addition, S35A and S39A point
mutations within this site 1 in GPSM3 also greatly reduced the
observed BRET signal as compared with the use of wild-type
GPSM3 (Fig. 4B), confirming the results obtained by co-immu-
noprecipitation (Fig. 2B).
We previously reported that GPSM3 associates with hetero-
trimeric G-protein  subunits (G) during their biosynthetic
pathway toward formation of the G heterodimer (20). This
GPSM3/G interaction was found to be independent of the
well established Gi/GDP interactions mediated by two of
three GoLoco motifs within GPSM3 (19). We employed the
BRET assay to evaluate the effect of 14-3-3 on both of these3 R31,34A  R31A and R34A.
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G-protein subunit interactions. Overexpression of 14-3-3 had
no effect on the BRET ratio generated by co-expression ofGi1-
RLuc/GFP10-GPSM3 fusion pairs or G1-RLuc/GFP10-
GPSM3 fusion pairs (Fig. 4, C and D).
Conversely, overexpression ofG1was seen to greatly reduce
the interaction between GPSM3 and 14-3-3, as shown both by
BRET (Fig. 4E) and by co-immunoprecipitation studies (Fig.
4F). Themechanismunderlying this unidirectionalmodulation
FIGURE 2. Identification of the 14-3-3 binding motif within GPSM3 and the endogenous GPSM3/14-3-3 interaction within THP-1 cells. A, point muta-
tions within a region comprising amino acids 31 and 40 of GPSM3 perturb its stable expression. Mutagenized, FLAG-tagged GPSM3 expression constructs were
transfected into HEK293 cells, and GPSM3 protein was immunoprecipitated (IP) using anti-FLAG M2 antibody. Immunoprecipitates were resolved by 4 –12%
SDS-PAGE and immunoblotted (IB) with anti-FLAG antibody. Lysates were resolved on 4 –12% SDS-PAGE and immunoblotted with anti--actin as loading
control. B–E, serines 35 and 39, as well as arginines 31 and 34, were identified as essential determinants for the interaction with 14-3-3 isoforms. Point-mutated,
FLAG-tagged GPSM3 constructs were co-transfected with HA-tagged, wild type 14-3-3  (B and C), / (D),  (E), 14-3-3 R56A mutant (F), and 14-3-3 S58A or
S58E mutants (G); immunoprecipitation was performed as in panel A and immunoblotted with anti-HA- and anti-FLAG-HRP conjugates. H, detection of an
endogenous GPSM3/14-3-3 interaction. Whole cell lysate from THP-1 cells was immunoprecipitated with the anti-GPSM3 mouse monoclonal antibody 35.5.1
(Ref. 20) or an IgG2 isotype control (left panel) or immunoprecipitated with the polyclonal pan anti-14-3-3 antibody or an IgG2 isotype control (right panel) and
subsequently detected using the polyclonal pan anti-14-3-3 antibody (left panel) or anti-GPSM3 mouse monoclonal antibody 35.5.1 (right panel).
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of the GPSM3/14-3-3 interaction by G subunit expression,
while 14-3-3 expression did not cause a reciprocal decrease in
GPSM3/G association, remains to be established, but it is
unlikely to be direct steric competition between G and 14-3-3
as this effect would have been seen to be bidirectional.
Direct Interaction between Recombinant GPSM3 and 14-3-3—
To confirm the direct interaction between GPSM3 and 14-3-3,
both proteins were first purified from recombinant expression
systems. His-tagged 14-3-3 was expressed in Escherichia coli,
purified by Ni-NTA affinity and size-exclusion chromatogra-
phies, and immobilized on a surface plasmon resonance (SPR)
biosensor chip as described previously (24); the E. coli-derived
14-3-3was dimeric, as assessed bymigration during calibrated
size-exclusion chromatography. Although GPSM3 was ex-
pressed and purified from E. coli, we also purified recombinant
GPSM3 protein using baculovirus-mediated expression in Sf9
insect cells in which endogenous protein serine/threonine
kinases are present. Recombinant GPSM3 purified from
E. coli was observed to interact with immobilized 14-3-3
(Fig. 5A), but apparently with lower affinity than GPSM3
purified from insect cells; i.e. the Sf9-sourced protein bound
immobilized 14-3-3 with higher apparent affinity (Fig. 5, A
and B), suggesting its phosphorylation during insect cell
expression. Given difficulties in attaining a true equilibrium
state or single-phase association/dissociation kinetics using
this SPR biosensor approach, we were unable to assign a
numerical dissociation constant (KD) value to the interaction
using either equilibrium or kinetic approaches; however,
based on the dose-response data obtained (e.g. Fig. 5B), we
estimate the KD for the GPSM3/14-3-3 interaction to be in
the submicromolar range.
Analysis of the GPSM3/14-3-3 Interaction and Subcellular
Localization by BiFC—BiFC is based on the reconstitution of
two unfolded counterparts, such as the N- and C-terminal
halves (YN andYC) of yellow fluorescent protein (YFP), to form
a stable fluorescent protein. In addition to confirming the inter-
action between two proteins, the fluorescent signal generated
can be used to locate the site of interaction within the cell by
simple fluorescence microscopy visualization (35). For exam-
ple, we previously used BiFC to show that the interaction
between GPSM3 and G subunits occurs in the cytoplasm and
can also form juxtanuclear aggregates (20). Here, the N-termi-
nal portion of YFP was fused to the N terminus of GPSM3
(YN-GPSM3), whereas the C-terminal fragment of YFP was
fused to the C terminus of 14-3-3 (14-3-3-YC). Expression of
each construct alone (YN-GPSM3 or 14-3-3-YC) or expression
of each fusion paired with the cognate fluorescent protein frag-
ment lacking the fusion bait gave no appreciable fluorescence,
as expected. In contrast, combining expression of YN-GPSM3
with 14-3-3-YC generated a strong BiFC signal (Fig. 6A).
Co-expression of nontagged 14-3-3 significantly inhibited
the BiFC signal (Fig. 6A), a measure of the specificity of the
GPSM3/14-3-3 interaction. Unlike the interaction between
GPSM3 andG subunits that was found to lead to juxtanuclear
aggregates over time (20), the interaction between GPSM3 and
14-3-3 observed by BiFC was diffusely located throughout the
cytoplasm and completely excluded from the nucleus. This pat-
tern of subcellular localization did not change over time after
transfection and was not affected by the level of expression (e.g.
Fig. 6B).
GPSM3 and 14-3-3 Mutually Affect Their Subcellular
Localizations—GPSM3 expression has previously been ob-
served throughout the cell including the nucleus, either when
overexpressed or at the endogenous level (20); therefore, we
next evaluated whether the interaction with 14-3-3 could reg-
ulate the subcellular localization of GPSM3. mCherry-tagged,
wild-type GPSM3 was seen to be distributed throughout trans-
fected cells, including the nucleus, but with amore pronounced
cytoplasmic localization than that seen in the nucleus (Fig. 7A).
In contrast, the 14-3-3 binding mutant of GPSM3 (R31,34A; as
an mCherry fusion) was observed to be evenly distributed
throughout transfected cells, without any distinction between
nuclear and cytosolic compartments (Fig. 7A). The presence of
ectopically expressed 14-3-3 increased the observed exclusion
ofwild-typeGPSM3 from thenucleus (Fig. 7B,panel ii), but had
no effect on the R31,34A mutant (Fig. 7B, panel iii). In these
studies, we found HA-tagged 14-3-3 to be distributed
throughout the cell when expressed alone (Fig. 7B, panel i) or
with the loss-of-function R31,34A GPSM3 mutant (Fig. 7B,
panel iii). On the other hand, HA-tagged 14-3-3 was excluded
from the nucleus in the presence of wild typemCherry-GPSM3
(Fig. 7B, panel ii).
Involvement of GSK3 Kinase in the GPSM3/14-3-3
Interaction—Based on in silico prediction and mutagenesis as
presented above, GPSM3 interacts with 14-3-3 through amode
II consensus 14-3-3 binding sequence R31PWR34S35AP. Muta-
tion of serine 35 completely abrogates the 14-3-3 interaction
(e.g. Fig. 2, B–F), suggesting that phosphorylation of serine 35 is
obligatory for 14-3-3 binding; the neighboring residue serine 39
also appears important as the interaction is greatly reduced
when serine 39 is mutated (Fig. 2).
In silico analyses of potential serine/threonine kinases that
could phosphorylate serine 35 (e.g. Scansite) reveal the mode
II consensus 14-3-3 binding sequence within GPSM3
(R31PWR34S35APPS39PP) as overlapping with a consensus site
for the glycogen synthase kinase 3 (GSK3) substrates ((S/
T)XXX(pS/T); Ref. 36), where the first S/T is the GSK3 phos-
FIGURE 3. Disruption of the interaction with 14-3-3 increases GPSM3 deg-
radation. HEK293 cells were transfected with FLAG-tagged GPSM3 wild type
(A) or (R31,34A) (B) mutant. 24 h after transfection, cells were treated with
cycloheximide (CHX, 200 
g/ml) for the indicated time prior to harvesting,
and lysates were resolved on 4 –12% SDS-PAGE and immunoblotted (IB) with
anti-FLAG and anti--actin antibodies. IP, immunoprecipitated.
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phorylation target,X is any amino acid, and pS/T is the priming
phosphorylation site. GSK3 has an unusual preference for sub-
strates that are prephosphorylated at a priming, C-terminal
Ser/Thr residue; this priming process, although not strictly
required, increases phosphorylation efficiency of the N-termi-
nal Ser/Thr by 100–1000-fold (37). Moreover, GSK3 favors the
presence of proline in the recognition site; for example, one of
theGSK3phosphorylation sites in glycogen synthase is SVPPpS
(38). GPSM3 serine 35, required for the 14-3-3 interaction, fits
perfectly into this GSK3 recognition sequence. Furthermore,
serine 39 was found to be phosphorylated in the mass spec-
trometry analysis of GPSM3 post-translational modifications
(supplemental Fig. S3), andmutation of the serine 39 to alanine
(S39A) reduces the GPSM3/14-3-3 interaction. As GPSM3 ser-
ine 39 is followed by a proline, we focused our studies onGSK3,
a potential proline-directed kinase (39–41), and other well
characterized, proline-directed serine/threonine kinases (e.g.
cyclin-dependent kinases (CDKs), c-Jun N-terminal kinases
(JNKs), p38, and extracellular-signal-regulated kinases 1/2
(ERK1/2).
FIGURE 4. Characterization of the GPSM3/14-3-3 interaction using BRET. A, the interaction between GPSM3 and 14-3-3 was confirmed by a BRET saturation
experiment. A constant amount of 14-3-3-RLuc fusion expression vector was co-transfected into HEK293 cells with increasing amounts of GFP10-GPSM3 fusion
expression vector; the resultant net BRET ratio was plotted as a function of the acceptor/donor ratio. The specificity of the interaction is indicated by the
saturable nature of the BRET signal. B, point mutations, previously found by co-immunoprecipitation to disrupt ((S35A) or (R31,34A)) or strongly reduce (S39A)
the GPSM3 interaction with 14-3-3, were introduced in the GFP10-GPSM3 construct and assayed by BRET for 14-3-3 interaction. C and D, the effect of 14-3-3 on
the previously described interactions between GPSM3 and Gi1 or G1 (20) was assayed by BRET. Gi1-RLuc or G1-Rluc expression constructs were co-
transfected in HEK293 cells with GFP10-GPSM3 (wild type or R31,34A mutant) in the presence or absence of 14-3-3 expression vector. E and F, G1 overex-
pression reduces interaction between GPSM3 and 14-3-3. E, nontagged G1 was co-expressed with the 14-3-3-RLuc/GFP10-GPSM3 BRET pair, and the effect on
BRET signal was measured. Error bars in panels A–E indicate S.E. F, FLAG-tagged GPSM3 (WT or R31,34A) constructs were co-transfected with HA-tagged,
wild-type 14-3-3 expression vector in the presence or absence of HA-tagged G1, and immunoprecipitation was performed using agarose-conjugated
anti-FLAG M2 antibody. Immunoprecipitates (IP) were resolved on a 4 –12% SDS-PAGE and immunoblotted (IB) with anti-HA- and anti-FLAG-HRP conjugates.
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As shown in Fig. 8A, neither U0126 (MEK1/2 inhibitor, an
upstream activator of ERK1/2) nor SB203580 (p38/ inhibitor)
had any effect on GPSM3 expression levels, even at high concen-
tration (10 
M). SP600125 (JNK inhibitor), olomoucine (CDK
inhibitor), and H89 (a broad range inhibitor often used to inhibit
PKA) were each seen to reduce GPSM3 expression levels. Most
dramatically, theGSK3/ inhibitor (SB216763)was foundtopro-
foundly reduce the level of ectopicGPSM3expression (Fig. 8A).
A similar effectwas observed on endogenousGPSM3expres-
sion in THP-1 cells, with expression reduced bymore than 75%
(Fig. 8B). None of the other, above mentioned inhibitors were
seen to have any effect on endogenous GPSM3 levels in THP-1
cells, although H89 treatment was found to drastically reduce
THP-1 cell viability.
Mammalian cells express two isoforms of GSK3, GSK3 and
GSK3, which share 98% sequence similarity in their kinase
domain. However, the isoforms are structurally and function-
ally distinct (42). There is anN-terminal glycine-rich extension in
FIGURE 5. Confirmation of the direct interaction between GPSM3 and
14-3-3 by SPR. A, recombinant 14-3-3 purified from E. coli was covalently
immobilized on a nickel-NTA SPR chip and recombinant GPSM3, purified
either from a bacterial (E. coli) or from an insect cell (Sf9) source, was super-
fused over the biosensor surface at 250 nM for 300 s. RU, resonance units; MBP,
maltose binding protein. B, SPR interaction experiment was performed as in
panel A, but with the indicated concentrations of Sf9-sourced recombinant
GPSM3 protein and a 180-s association time.
FIGURE 6. Analysis of the GPSM3 and 14-3-3 interaction using BiFC. A and
B, HEK293 were transfected with plasmids expressing YN-GPSM3 (amino
acids 1–158 of YFP fused to GPSM3) and 14-3-3-YC (14-3-3 fused to amino
acids 159 –238 of YFP), and the fluorescence from the assembled YFP fluoro-
phore was assayed at 24 h after transfection. A, cells were harvested, and
fluorescence was quantified on a plate reader. Total DNA used for transfec-
tion was normalized using empty pcDNA3.1 vector DNA. Error bars indicate
S.E. RFU, relative fluorescence units. B, epifluorescence microscopy images of
HEK293 cells transfected with plasmids expressing the two YFP protein frag-
ment fusions as in panel A show an exclusively cytoplasmic localization of the
reconstituted fluorescent complex.
FIGURE 7. GPSM3 and 14-3-3 mutually regulate their subcellular localiza-
tion. HEK293 were transfected with mCherry-tagged GPSM3 (either wild type
or R31,34A mutant) or nontagged mCherry expression vectors in the absence
(A) or presence (B) of HA-tagged 14-3-3 (green) expression vector. After 24 h,
cells were fixed and labeled with an anti-HA-FITC antibody conjugate and
mounted with VECTASHIELD containing the nuclear stain DAPI (blue). A,
mCherry-GPSM3 (wild type) was found to have a prominent cytosolic local-
ization as compared with the (R31,34A) variant. B, co-expression of 14-3-3
increased the cytosolic partitioning of mCherry-GPSM3 (wild type), but not of
the (R31,34A) mutant. Similarly, co-expression of mCherry-GPSM3 (wild type)
induced nuclear exclusion of the subcellular localization of 14-3-3 as com-
pared with co-expression of the (R31,34A) mutant or nontagged mCherry
protein. Cell numbering in panel B (panel ii) indicates (1) a cell expressing
solely mCherry-GPSM3 versus (2) a cell in the same field co-expressing
mCherry-GPSM3 and HA-14-3-3. Note the heightened degree of nuclear
exclusion of wild-type mCherry-GPSM3 expression in cell 2 versus cell 1. Cells
imaged are representative of the majority of cells present.
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GSK3 as well as distinct C-terminal regions (only 38% similarity
between isoforms). When co-expressed in HEK293 cells, GSK3,
but notGSK3, was found in complexwith FLAG-taggedGPSM3
(Fig. 8C). The exclusion of GSK3, even when overexpressed,
highlights the unique nature and specificity of this GSK3/
GPSM3 interaction. Todate, only the protein adaptor RACK1has
been shown to selectively interactwithGSK3, an interaction that
involves the unique N-terminal extension of GSK3 (43). The
mechanism bywhichGSK3 is recruited toGPSM3 as well as the
regulation of this interaction is unknown.
Conclusions—A single 14-3-3 binding site exists in GPSM3
and corresponds to a consensus mode II binding motif, RX(/
S)()(pS)XP, in which position P0 is an obligatory pS known to
interact with positively charged arginine 56 and 127 within the
14-3-3 binding groove ( isoform numbering). The arginine at
position P4 forms an intramolecular salt bridge with the P0
phosphoserine, and the proline at position P2 orients themain
chain direction of the binding peptide (25). The binding site
within GPSM3 (RPWRS35AP) contains all requirements for an
optimal, high affinity interaction; mutagenesis confirmed the
critical role of these elements as the R31,34A and S35Amutants
of GPSM3 completely abolish interaction with 14-3-3. Addi-
tionally, the R56A 14-3-3mutant exhibited reduced interaction
withGPSM3. Co-immunoprecipitation of endogenousGPSM3
and 14-3-3 proteins from the humanmonocytic cell line THP-1
suggests basal phosphorylation ofGPSM3 at serine 35 as poten-
tially mediated by GSK3. The GPSM3/14-3-3 interaction is
seen to stabilize GPSM3 from degradation and also support the
nuclear exclusion of both proteins. Future studies will be
directed at establishing the specific roles of these newly
described 14-3-3 and GSK3 interactions in the G-protein
modulatory functions of GPSM3 within immune system cells.
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